vs

Side-by-side financial comparison of TECHPRECISION CORP (TPCS) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

Wave Life Sciences Ltd. is the larger business by last-quarter revenue ($8.7M vs $7.1M, roughly 1.2× TECHPRECISION CORP). TECHPRECISION CORP runs the higher net margin — -20.8% vs -580.2%, a 559.4% gap on every dollar of revenue. On growth, TECHPRECISION CORP posted the faster year-over-year revenue change (-6.9% vs -55.8%). TECHPRECISION CORP produced more free cash flow last quarter ($-827.0K vs $-46.3M). Over the past eight quarters, TECHPRECISION CORP's revenue compounded faster (-9.2% CAGR vs -18.0%).

TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

TPCS vs WVE — Head-to-Head

Bigger by revenue
WVE
WVE
1.2× larger
WVE
$8.7M
$7.1M
TPCS
Growing faster (revenue YoY)
TPCS
TPCS
+48.9% gap
TPCS
-6.9%
-55.8%
WVE
Higher net margin
TPCS
TPCS
559.4% more per $
TPCS
-20.8%
-580.2%
WVE
More free cash flow
TPCS
TPCS
$45.5M more FCF
TPCS
$-827.0K
$-46.3M
WVE
Faster 2-yr revenue CAGR
TPCS
TPCS
Annualised
TPCS
-9.2%
-18.0%
WVE

Income Statement — Q3 FY2026 vs Q2 FY2025

Metric
TPCS
TPCS
WVE
WVE
Revenue
$7.1M
$8.7M
Net Profit
$-1.5M
$-50.5M
Gross Margin
5.4%
Operating Margin
-19.1%
-606.5%
Net Margin
-20.8%
-580.2%
Revenue YoY
-6.9%
-55.8%
Net Profit YoY
-84.4%
-53.3%
EPS (diluted)
$-0.15
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TPCS
TPCS
WVE
WVE
Q4 25
$7.1M
Q3 25
$9.1M
Q2 25
$7.4M
$8.7M
Q1 25
$9.5M
$9.2M
Q4 24
$7.6M
Q3 24
$8.9M
Q2 24
$8.0M
$19.7M
Q1 24
$8.6M
$12.5M
Net Profit
TPCS
TPCS
WVE
WVE
Q4 25
$-1.5M
Q3 25
$825.0K
Q2 25
$-597.0K
$-50.5M
Q1 25
$112.0K
$-46.9M
Q4 24
$-799.0K
Q3 24
$-601.0K
Q2 24
$-1.5M
$-32.9M
Q1 24
$-5.1M
$-31.6M
Gross Margin
TPCS
TPCS
WVE
WVE
Q4 25
5.4%
Q3 25
27.1%
Q2 25
14.0%
Q1 25
22.0%
Q4 24
13.0%
Q3 24
11.3%
Q2 24
3.0%
Q1 24
14.3%
Operating Margin
TPCS
TPCS
WVE
WVE
Q4 25
-19.1%
Q3 25
10.4%
Q2 25
-6.3%
-606.5%
Q1 25
3.9%
-542.8%
Q4 24
-9.1%
Q3 24
-5.5%
Q2 24
-16.8%
-177.7%
Q1 24
-28.6%
-274.8%
Net Margin
TPCS
TPCS
WVE
WVE
Q4 25
-20.8%
Q3 25
9.1%
Q2 25
-8.1%
-580.2%
Q1 25
1.2%
-510.9%
Q4 24
-10.5%
Q3 24
-6.7%
Q2 24
-18.3%
-167.2%
Q1 24
-59.5%
-251.7%
EPS (diluted)
TPCS
TPCS
WVE
WVE
Q4 25
$-0.15
Q3 25
$0.08
Q2 25
$-0.06
$-0.31
Q1 25
$0.01
$-0.29
Q4 24
$-0.08
Q3 24
$-0.06
Q2 24
$-0.16
$-0.25
Q1 24
$-0.59
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TPCS
TPCS
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$50.0K
$208.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$8.0M
$139.3M
Total Assets
$32.8M
$252.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TPCS
TPCS
WVE
WVE
Q4 25
$50.0K
Q3 25
$220.0K
Q2 25
$143.0K
$208.5M
Q1 25
$195.0K
$243.1M
Q4 24
$165.0K
Q3 24
$132.0K
Q2 24
$44.8K
$154.0M
Q1 24
$138.0K
$180.9M
Total Debt
TPCS
TPCS
WVE
WVE
Q4 25
Q3 25
Q2 25
Q1 25
$3.0K
Q4 24
$19.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
TPCS
TPCS
WVE
WVE
Q4 25
$8.0M
Q3 25
$9.1M
Q2 25
$8.2M
$139.3M
Q1 25
$8.7M
$171.8M
Q4 24
$8.1M
Q3 24
$8.9M
Q2 24
$7.9M
$-3.5M
Q1 24
$7.8M
$25.4M
Total Assets
TPCS
TPCS
WVE
WVE
Q4 25
$32.8M
Q3 25
$33.8M
Q2 25
$32.1M
$252.4M
Q1 25
$33.5M
$288.3M
Q4 24
$32.2M
Q3 24
$35.0M
Q2 24
$35.7M
$208.8M
Q1 24
$34.7M
$235.3M
Debt / Equity
TPCS
TPCS
WVE
WVE
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TPCS
TPCS
WVE
WVE
Operating Cash FlowLast quarter
$183.0K
$-46.0M
Free Cash FlowOCF − Capex
$-827.0K
$-46.3M
FCF MarginFCF / Revenue
-11.7%
-532.5%
Capex IntensityCapex / Revenue
14.2%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-4.4M
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TPCS
TPCS
WVE
WVE
Q4 25
$183.0K
Q3 25
$-1.1M
Q2 25
$646.0K
$-46.0M
Q1 25
$396.0K
$-63.0M
Q4 24
$-570.0K
Q3 24
$-532.0K
Q2 24
$107.0K
$-27.5M
Q1 24
$-452.0K
$-33.4M
Free Cash Flow
TPCS
TPCS
WVE
WVE
Q4 25
$-827.0K
Q3 25
$-2.1M
Q2 25
$-604.0K
$-46.3M
Q1 25
$-930.0K
$-63.2M
Q4 24
$-1.7M
Q3 24
$-2.0M
Q2 24
$-94.0K
$-27.5M
Q1 24
$-900.0K
$-33.8M
FCF Margin
TPCS
TPCS
WVE
WVE
Q4 25
-11.7%
Q3 25
-22.9%
Q2 25
-8.2%
-532.5%
Q1 25
-9.8%
-688.9%
Q4 24
-22.9%
Q3 24
-21.8%
Q2 24
-1.2%
-139.8%
Q1 24
-10.5%
-270.0%
Capex Intensity
TPCS
TPCS
WVE
WVE
Q4 25
14.2%
Q3 25
11.0%
Q2 25
16.9%
3.5%
Q1 25
14.0%
1.8%
Q4 24
15.4%
Q3 24
15.9%
Q2 24
2.5%
0.3%
Q1 24
5.2%
3.3%
Cash Conversion
TPCS
TPCS
WVE
WVE
Q4 25
Q3 25
-1.31×
Q2 25
Q1 25
3.54×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TPCS
TPCS

Defense$6.7M94%
Other$410.0K6%

WVE
WVE

Segment breakdown not available.

Related Comparisons